These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4177792)

  • 1. [On immunoinsufficiency in chronic uremic kidney diseases].
    Scheurlen PG; Baake M; Frey N; Moers P; Sieberth G
    Dtsch Med Wochenschr; 1969 Jan; 94(1):17-20 passim. PubMed ID: 4177792
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studying the immune reactivity of uremic patients by phytohemagglutinin-stimulated lymphocyte culture].
    Petri I; Gál G; Kaiser G; Maráz A
    Orv Hetil; 1974 Mar; 115(11):613-5. PubMed ID: 4815461
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune system dysregulation in uremia.
    Descamps-Latscha B; Herbelin A; Nguyen AT; Zingraff J; Jungers P; Chatenoud L
    Semin Nephrol; 1994 May; 14(3):253-60. PubMed ID: 8036360
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunological parameters in uremic patients under hemodialysis].
    Pigareva NV; Polenova IM
    Klin Med (Mosk); 1981 Mar; 59(3):75-9. PubMed ID: 7265837
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological considerations of the uremic and dialyzed patient.
    Chatenoud L; Jungers P; Descamps-Latscha B
    Kidney Int Suppl; 1994 Jan; 44():S92-6. PubMed ID: 8127041
    [No Abstract]   [Full Text] [Related]  

  • 6. [Impaired lymphoblastoid cell transformation in chronic renal diseases].
    Shishido H; Okuda M
    Naika; 1970 Feb; 25(2):339-44. PubMed ID: 4191342
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of interferon response in lymphocytes from patients with uremia.
    Sanders CV; Luby JP; Sanford JP; Hull AR
    J Lab Clin Med; 1971 May; 77(5):768-76. PubMed ID: 5557663
    [No Abstract]   [Full Text] [Related]  

  • 8. [Odonto-stomatologic aspects of immunologic maturation and its primary deficiencies].
    Dachy A
    Rev Belge Med Dent; 1968; 23(2):117-28. PubMed ID: 4180720
    [No Abstract]   [Full Text] [Related]  

  • 9. On the mechanism of cell-mediated immunodeficiency in chronic renal failure.
    Shahin MH; Afifi N; El Sheemy N; Mohamed AA; Barsoum RS
    J Egypt Med Assoc; 1977; 60(5-6):385-95. PubMed ID: 314949
    [No Abstract]   [Full Text] [Related]  

  • 10. [On protein loss after peritoneal dialysis in chronic renal insufficiency].
    Zucchelli P; Caudarella R; Bonomini V
    Minerva Nefrol; 1967; 14(4):177-8. PubMed ID: 4179754
    [No Abstract]   [Full Text] [Related]  

  • 11. Dinitrochlorobenzene contact sensitization in patients with end-stage renal disease.
    Waltzer WC; Gonder MJ
    Allergol Immunopathol (Madr); 1984; 12(6):479-82. PubMed ID: 6335629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte transformation in chronic renal failure.
    Nakhla LS; Goggin MJ
    Immunology; 1973 Feb; 24(2):229-35. PubMed ID: 4693640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The humoral immunologic picture in repeatedly dialyzed patients as compared with those with residual diuresis].
    Ursea N; Cristian R; Penescu M; Patrichi D; Călăraşu P; Luban F
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(6):541-4. PubMed ID: 6143376
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sepsis in patients with terminal chronic kidney failure (a review of the literature)].
    Filiptsev PIa; Vetchinnikova ON; Cherniakov VL
    Khirurgiia (Mosk); 1988 Mar; (3):131-7. PubMed ID: 3290567
    [No Abstract]   [Full Text] [Related]  

  • 15. [Further studies on the cellular defense mechanism in patients with terminal kidney failure and on treatment using intermittent hemodialysis].
    Reis HE; Cremer W; Heimsoth VH; Wetter O; Eitelhuber U
    Verh Dtsch Ges Inn Med; 1974; 80():749-52. PubMed ID: 4548993
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasmapheresis holds distinct advantages for 21st century uremia therapy.
    Nose Y; Smith JW; Malchesky PS
    Kidney Int Suppl; 1985 Dec; 17():S131-2. PubMed ID: 3867783
    [No Abstract]   [Full Text] [Related]  

  • 17. Proliferation in autologous mixed lymphocyte reactions, expression of HLA-class II antigen and serum immunomodulatory activity in patients with renal insufficiency on chronic dialysis.
    Puppo F; Gurreri G; Pattarini R; Ranise A; Indiveri F
    Allergol Immunopathol (Madr); 1991; 19(4):167-73. PubMed ID: 1840170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of middle molecules on immunological functions.
    Navarro J; Contreras P; Touraine JL; Freyria AM; Later R; Traeger J
    Artif Organs; 1981; 4 Suppl():76-81. PubMed ID: 7028006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Outline of immune deficiency pathogenesis in patients with chronic renal failure].
    Zmonarski SC; Klinger M; Puziewicz-Zmonarska A
    Postepy Hig Med Dosw; 1995; 49(4):487-512. PubMed ID: 8657644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractions of middle molecular weight responsible for immunodeficiency in malnourished and burnt patients.
    Gay G; Touraine JL; Touraine F; Freyria AM; Traeger J; Navarro J
    Artif Organs; 1981; 4 Suppl():71-5. PubMed ID: 6794551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.